Similar articles

• Relationship between serum vitamin D concentrations and clinical outcome of community-acquired pneumonia.

  Kim HJ, Jang JG, Hong KS, Park JK, Choi EY. Kim HJ, et al. Int J Tuberc Lung Dis. 2015 Jun;19(6):729-34. doi: 10.5588/ijtld.14.0696. Int J Tuberc Lung Dis. 2015. PMID: 25946368
• Effect of adjunctive single high-dose vitamin D₃ on outcome of community-acquired pneumonia in hospitalised adults: The VIDCAPS randomised controlled trial.

  Slow S, Epton M, Storer M, Thiessen R, Lim S, Wong J, Chin P, Tovaranonte P, Pearson J, Chambers ST, Murdoch DR; VIDCAPS Group. Slow S, et al. Sci Rep. 2018 Sep 14;8(1):13829. doi: 10.1038/s41598-018-32162-2. Sci Rep. 2018. PMID: 30218062 Free PMC article. Clinical Trial.
• Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia.

  Remmelts HH, van de Garde EM, Meijvis SC, Peelen EL, Damoiseaux JG, Grutters JC, Biesma DH, Bos WJ, Rijkers GT. Remmelts HH, et al. Clin Infect Dis. 2012 Dec;55(11):1488-94. doi: 10.1093/cid/cis751. Epub 2012 Aug 31. Clin Infect Dis. 2012. PMID: 22942205
• [Treatment of vitamin D deficiency in the general population and in patients with chronic kidney disease].

  Mozzillo GR, Scognamiglio B, Russo D. Mozzillo GR, et al. G Ital Nefrol. 2015 Jul-Aug;32(4):gin/32.4.3. G Ital Nefrol. 2015. PMID: 26252259 Review. Italian.
• Genetic defects in vitamin utilization. Part I: General aspects and fat-solumbe vitamins.

  Elsas LJ, McCormick DB. Elsas LJ, et al. Vitam Horm. 1986;43:103-44. doi: 10.1016/s0083-6729(08)60419-7. Vitam Horm. 1986. PMID: 3538647 Review. No abstract available.